Dr Daria Donati presented today at the World Vaccine Congress in Washington about the vaccine market landscape and the role of emerging economies.
There is a strong and growing global market in biologicals – demand doubled from 2006-2011. New manufacturing approaches are needed that are tailored to the needs of emerging countries.
A key way to bring down costs is create packaged and flexible solution by looking at the facility, the process and the project. All of these help speed a product to market.
Donati presented a case study in which a facility would be used for influenza and rotovirus vaccine production. Space was allocated for production that had a small footprint and could be easily shifted from one to the other vaccine manufacture in a very short period of time. The goal was to get per dose cost under $1.00.
Manufacturing cost effectiveness resides in a package approach. This is done by maximizing fixed investment utilization (the facility), manufacturing process optimization, and combining the most advanced technologies and one point of contact management. This approach speeds time to market.
Getting to market more quickly brings immediate cost benefits. Six months advanced market entry can mean 2.5 million additional vaccine doses to meet healthcare needs.
Check back here in a couple of days for the presentation.